Prostate Cancer Imaging
Curium Austria GmbH is involved in clinical research focused on prostate cancer, with interest in diagnostic imaging for men with clinical suspicion of disease and elevated PSA or PSA density. The research activity centres on identifying clinically significant disease in the setting of equivocal MRI findings and PI-RADS-based assessment.
- Positron emission tomography
- Computed tomography
- Molecular imaging
- Multiparametric MRI
The sponsor’s research interest includes the clinical use of 18F-labelled PET tracers for localising clinically significant prostate cancer in patients with indeterminate imaging findings.
